비구아나이드 시장 규모는 향후 몇 년 동안 안정적인 성장을 보일 것으로 예상되며, 2029년까지 3.7%의 연평균 복합 성장률(CAGR)로 59억 8,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 성장의 배경에는 병용요법의 채택 확대, 약물 전달 기술의 발전, R&D 투자 증가, 헬스케어 지출 증가, 다낭성 난소 증후군 치료에 대한 적용 확대 등이 있습니다. 예측 기간 동안 주요 동향으로는 서방형 제제 개발에 대한 관심 증가, 병용요법에 대한 선호도 증가, 암 분야에서의 적용 확대, 효능과 안전성 프로파일을 개선한 새로운 비구아나이드의 출현 등이 있습니다.
당뇨병 환자 증가는 당분간 비구아나이드 시장의 성장을 견인할 것으로 예측됩니다. 당뇨병은 인슐린 분비 부족으로 인한 혈당 상승을 특징으로 하는 만성 대사성 질환으로, 생활습관 변화, 인구 고령화, 유전적 요인, 진단 방법의 개선, 환경적 영향 등 다양한 요인으로 인해 증가 추세에 있습니다. 메트포르민과 같은 비구아나이드는 인슐린 감수성을 높이고 간에서 포도당 생성을 억제하여 2형 당뇨병 환자의 혈당 수치를 낮춤으로써 당뇨병 관리에 도움을 줄 수 있습니다. 예를 들어, 영국 정부 부서인 Office for Health Improvement &&Disparities에 따르면, 2022년 3월부터 2023년 3월까지 1형 당뇨병과 2형 당뇨병에 대해 권장되는 8가지 치료 과정을 모두 받는 사람의 비율이 크게 증가했습니다. 또한 HbA1c 목표치를 달성한 사람의 비율은 37.9%로 사상 최고치를 기록했습니다. 따라서 당뇨병 유병률 증가는 비구아나이드 시장의 성장을 가속하고 있습니다.
비구아나이드 시장의 주요 업체들은 환자의 순응도를 높이고 치료 효과를 개선하며 부작용을 최소화하기 위해 서방형 제제와 같은 고급 솔루션 개발에 주력하고 있습니다. 서방형 비구아니드는 유효 성분을 천천히 방출하여 당뇨병 환자의 혈중 농도를 일정하게 유지하여 혈당 조절을 개선하고 치료 순응도를 높입니다. 예를 들어, 2023년 8월, 인도의 생명공학 기업 Dr. Reddy's Laboratories는 미국 식품의약국(USFDA)의 승인을 받은 KOMBIGLYZE XR의 제네릭 의약품인 삭사글립틴과 메트포르민 염산염 서방형 제제를 출시했습니다. 출시하였습니다. 본 제제는 DPP-4 억제제인 삭사글립틴과 비구아나이드계 약제인 메트포르민의 복합제로, 식이요법 및 운동요법과 병용하여 성인 2형 당뇨병 환자의 혈당 조절을 개선하는 것을 목적으로 합니다. 서방형 제제는 환자의 복약 순응도와 효능을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 비구아니드 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 비구아니드 시장 : 성장률 분석
- 세계의 비구아니드 시장 실적 : 규모와 성장, 2019-2024
- 세계의 비구아니드 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 비구아니드 전체 시장(TAM)
제6장 시장 세분화
- 세계의 비구아니드 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Metformin
- Phenformin
- 기타 유형
- 세계의 비구아니드 시장 : 제형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 정제
- 경구 용액
- 세계의 비구아니드 시장 : 처방별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Immediate-Release Metformin
- Extended-Release Metformin
- 세계의 비구아니드 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 비구아니드 시장 : Metformin 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Immediate-Release Metformin
- Extended-Release Metformin
- 세계의 비구아니드 시장 : Phenformin 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Phenformin Hydrochloride
- 세계의 비구아니드 시장 : 기타 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Buformin
- Metformin Combinations
제7장 지역별/국가별 분석
- 세계의 비구아니드 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 비구아니드 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 비구아니드 시장 : 경쟁 구도
- 비구아니드 시장 : 기업 개요
- Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- AstraZeneca plc
- Novartis AG
- GlaxoSmithKline plc
- Takeda Pharmaceuticals Company Limited
- Novo Nordisk A/S
- Viatris Inc.
- Daiichi Sankyo Company Limited
- Wanbury Ltd
- Boehringer Ingelheim International GmbH
- Intas Pharmaceuticals Ltd.
- Aurobindo Pharma Ltd.
- Cipla Ltd
- Shionogi & Co. Ltd.
- Dr. Reddy's Laboratories
- Lupin Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 비구아니드 시장(2029년) : 새로운 기회를 제공하는 국가
- 비구아니드 시장(2029년) : 새로운 기회를 제공하는 부문
- 비구아니드 시장(2029년) : 성장 전략
제36장 부록
LSH
Biguanides comprise a class of medications primarily employed in the treatment of type 2 diabetes. They aid in lowering blood sugar levels by reducing the liver's production of sugar and enhancing the body's responsiveness to insulin. Additionally, these medications find utility in treating polycystic ovary syndrome (PCOS) and other metabolic disorders.
The primary types of biguanides include metformin, phenformin, and others. Metformin stands out as a widely utilized biguanide medication for type 2 diabetes management, effectively lowering blood sugar levels. Available in various dosage forms such as tablets and oral solutions, metformin is offered in different formulations including immediate-release and extended-release variants. These medications are distributed through a variety of channels including hospital pharmacies, retail pharmacies, and online platforms.
The biguanides market research report is one of a series of new reports from The Business Research Company that provides biguanides market statistics, including biguanides industry global market size, regional shares, competitors with a biguanides market share, detailed biguanides market segments, market trends and opportunities, and any further data you may need to thrive in the biguanides industry. This biguanides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biguanides market size has grown steadily in recent years. It will grow from $4.96 billion in 2024 to $5.16 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to a rise in demand for oral hypoglycemic drugs, growth in the geriatric population, rise in obesity rates, and increased awareness about diabetes management.
The biguanides market size is expected to see steady growth in the next few years. It will grow to $5.98 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to the growing adoption of combination therapies, advancements in drug delivery technologies, increasing investment in research and development, rising healthcare expenditure, and expanding applications in the treatment of polycystic ovary syndrome. Major trends in the forecast period include increasing focus on developing extended-release formulations, growing preference for fixed-dose combination therapies, expanding applications in oncology, and the emergence of novel biguanides with improved efficacy and safety profiles.
The increase in diabetes cases is anticipated to drive the expansion of the biguanides market in the foreseeable future. Diabetes, a chronic metabolic disorder characterized by elevated blood sugar levels due to insufficient insulin production, is on the rise due to various factors such as lifestyle shifts, population aging, genetic factors, improved diagnostic methods, and environmental influences. Biguanides such as metformin help manage diabetes by enhancing insulin sensitivity, reducing liver glucose production, and lowering blood sugar levels in individuals with type 2 diabetes. For example, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals receiving all eight recommended care processes for type 1 and type 2 diabetes increased significantly. Additionally, the percentage of individuals achieving target HbA1c levels reached a record high of 37.9%. Therefore, the increasing prevalence of diabetes is propelling the growth of the biguanides market.
Leading companies in the biguanides market are concentrating on developing advanced solutions such as extended-release formulations to enhance patient compliance, improve therapeutic effectiveness, and minimize side effects. Extended-release biguanides slowly release their active ingredients, ensuring consistent blood levels and better glycemic control for diabetes patients, thereby enhancing treatment adherence. For instance, in August 2023, Dr. Reddy's Laboratories, an India-based biotechnology company, introduced saxagliptin and metformin hydrochloride extended-release drugs, a generic version of KOMBIGLYZE XR approved by the US Food and Drug Administration (USFDA). This combination medication, consisting of saxagliptin, a DPP-4 inhibitor, and metformin, a biguanide, aims to improve glycemic control in adults with type 2 diabetes mellitus when used in conjunction with diet and exercise. The extended-release formulation enhances patient adherence and efficacy.
In August 2023, Lupin, an India-based biopharmaceutical company, acquired diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim for an undisclosed sum. This acquisition enables Lupin to expand its product portfolio and strengthen its position in the anti-diabetes segment, ensuring broader access to medication for patients. Boehringer Ingelheim, a Germany-based biopharmaceutical company, is renowned for its research, development, and production of therapies for both human and veterinary medicine.
Major companies operating in the biguanides market are Cardinal Health Inc., Pfizer Inc., Merck And Co Inc, Bayer AG, Sanofi-Aventis LLC, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Company Limited, Novo Nordisk A/S, Viatris Inc., Daiichi Sankyo Company Limited, Wanbury Ltd, Boehringer Ingelheim International GmbH, Intas Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Cipla Ltd, Shionogi & Co Ltd, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Apotex Inc, Torrent Pharmaceuticals Limited, Panacea Biotech Ltd., Auro Laboratories Limited
Asia-Pacific was the largest region in the biguanides market in 2024. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biguanides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The biguanides market consists of sales of Chlorhexidine, Polyhexanide, Proguanil, and Buformin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biguanides Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biguanides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biguanides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biguanides market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Metformin; Phenformin; Other Types
- 2) By Dosage Form: Tablets; Oral Solutions
- 3) By Formulation: Immediate Release; Extended Release
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Metformin: Immediate-Release Metformin; Extended-Release Metformin
- 2) By Phenformin: Phenformin Hydrochloride
- 3) By Other Types: Buformin; Metformin Combinations
- Companies Mentioned: Cardinal Health Inc.; Pfizer Inc.; Merck And Co Inc; Bayer AG; Sanofi-Aventis LLC
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biguanides Market Characteristics
3. Biguanides Market Trends And Strategies
4. Biguanides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Biguanides Growth Analysis And Strategic Analysis Framework
- 5.1. Global Biguanides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Biguanides Market Growth Rate Analysis
- 5.4. Global Biguanides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Biguanides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Biguanides Total Addressable Market (TAM)
6. Biguanides Market Segmentation
- 6.1. Global Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metformin
- Phenformin
- Other Types
- 6.2. Global Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Oral Solutions
- 6.3. Global Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immediate Release
- Extended Release
- 6.4. Global Biguanides Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.5. Global Biguanides Market, Sub-Segmentation Of Metformin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immediate-Release Metformin
- Extended-Release Metformin
- 6.6. Global Biguanides Market, Sub-Segmentation Of Phenformin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Phenformin Hydrochloride
- 6.7. Global Biguanides Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Buformin
- Metformin Combinations
7. Biguanides Market Regional And Country Analysis
- 7.1. Global Biguanides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Biguanides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Biguanides Market
- 8.1. Asia-Pacific Biguanides Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biguanides Market
- 9.1. China Biguanides Market Overview
- 9.2. China Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biguanides Market
- 10.1. India Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biguanides Market
- 11.1. Japan Biguanides Market Overview
- 11.2. Japan Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biguanides Market
- 12.1. Australia Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biguanides Market
- 13.1. Indonesia Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biguanides Market
- 14.1. South Korea Biguanides Market Overview
- 14.2. South Korea Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biguanides Market
- 15.1. Western Europe Biguanides Market Overview
- 15.2. Western Europe Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biguanides Market
- 16.1. UK Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biguanides Market
- 17.1. Germany Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biguanides Market
- 18.1. France Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biguanides Market
- 19.1. Italy Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biguanides Market
- 20.1. Spain Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biguanides Market
- 21.1. Eastern Europe Biguanides Market Overview
- 21.2. Eastern Europe Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biguanides Market
- 22.1. Russia Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biguanides Market
- 23.1. North America Biguanides Market Overview
- 23.2. North America Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biguanides Market
- 24.1. USA Biguanides Market Overview
- 24.2. USA Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Biguanides Market
- 25.1. Canada Biguanides Market Overview
- 25.2. Canada Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biguanides Market
- 26.1. South America Biguanides Market Overview
- 26.2. South America Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biguanides Market
- 27.1. Brazil Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biguanides Market
- 28.1. Middle East Biguanides Market Overview
- 28.2. Middle East Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biguanides Market
- 29.1. Africa Biguanides Market Overview
- 29.2. Africa Biguanides Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Biguanides Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Biguanides Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biguanides Market Competitive Landscape And Company Profiles
- 30.1. Biguanides Market Competitive Landscape
- 30.2. Biguanides Market Company Profiles
- 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis
31. Biguanides Market Other Major And Innovative Companies
- 31.1. AstraZeneca plc
- 31.2. Novartis AG
- 31.3. GlaxoSmithKline plc
- 31.4. Takeda Pharmaceuticals Company Limited
- 31.5. Novo Nordisk A/S
- 31.6. Viatris Inc.
- 31.7. Daiichi Sankyo Company Limited
- 31.8. Wanbury Ltd
- 31.9. Boehringer Ingelheim International GmbH
- 31.10. Intas Pharmaceuticals Ltd.
- 31.11. Aurobindo Pharma Ltd.
- 31.12. Cipla Ltd
- 31.13. Shionogi & Co. Ltd.
- 31.14. Dr. Reddy's Laboratories
- 31.15. Lupin Limited
32. Global Biguanides Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Biguanides Market
34. Recent Developments In The Biguanides Market
35. Biguanides Market High Potential Countries, Segments and Strategies
- 35.1 Biguanides Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Biguanides Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Biguanides Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
